N/A
N=9,110
Assessment of Somatic Symptom in Chinese Community-Dwelling People
Somatization Disorder
Bottom Line
View on ClinicalTrials.gov: NCT04815863 ↗Enrolled (actual)
9,110
Serious AEs
0.0%
Results posted
Oct 2025
Primary outcome: Primary: Number of Participants With Somatic Symptoms Disorder — 4307; 1000; 2507; 1206 Participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Assessment of somatic symptom disorder with SSS-CN (Diagnostic_test); Assessment of depressive symptoms disorder with PHQ-9 (Diagnostic_test); Assessment of anxiety disorder with GAD-7 (Diagnostic_test)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- RenJi Hospital
- Primary completion
- Jun 2019
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Somatic Symptoms Disorder |
4307; 1000; 2507; 1206 | — |
Summary
With the rapid aging and worsening psychological problems worldwide, the special focus on somatic symptom and other psychological diseases of the older population is needed. However, there is no research comparing the incidence of somatic symptom between elderly and non-elderly, and clinical relevance with somatic symptom is uncertain. The study aims to clarify the prevalence of somatic symptom, depression and anxiety disorders in China, to compare physical and psychological difference between the elderly and non-elderly and to explore risk factors for somatic symptom in the elderly.
Eligibility Criteria
Inclusion Criteria
- voluntary participants and gave written consent to participates the study;
- undertook SSS-CN questionnaire, PHQ-9 and GAD questionnaires;
Exclusion Criteria
- patients who have lost their self-assessed abilities or refuse to participate ;
- patient with cancer and central nervous system disease;
- patients who have been previously confirmed serious mental disorders, mental retardation or dementia.
Data sourced from ClinicalTrials.gov (NCT04815863). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.